Completed
Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian Cancer
NCT03430518
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +18 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States